" It is imperative that the Company generate unassailable results in the clinic and I believe the above trials can accomplish this."

Well alright then & Dr. J has been @ Cytodyn much longer than the avg shareholder realizes.

Taken as closed issue on which path for adding value to the patents.

So expecting no more shuffling & we're off to the races.

Wow what a journey.

Shall see....